
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
Update: 2025-03-16
Share
Description
Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.
Comments
In Channel